Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
11.07
+0.02 (0.18%)
At close: Sep 16, 2026, 4:00 PM EDT
11.04
-0.03 (-0.27%)
After-hours: Sep 16, 2026, 4:10 PM EDT
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $386.15 million as of September 16, 2026. Its market cap has increased by 7.37% in one year.
Market Cap
386.15M
Enterprise Value
206.94M
1-Year Change
7.37%
Ranking
Category
Stock Price
$11.07
ChartMarket Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $386.15M, a decrease of -82.66%. That is a compound annual growth rate of -13.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 386.15M | -15.34% |
| Dec 31, 2025 | 456.12M | 55.56% |
| Dec 31, 2024 | 293.22M | 3,429.00% |
| Dec 29, 2023 | 8.31M | 74.68% |
| Dec 30, 2022 | 4.76M | -77.78% |
| Dec 31, 2021 | 21.41M | 61.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Larimar Therapeutics | 408.14M |
| Editas Medicine | 403.92M |
| Turn Therapeutics | 400.95M |
| BridgeBio Oncology Therapeutics | 391.25M |
| vTv Therapeutics | 378.46M |
| Galectin Therapeutics | 376.17M |
| Rocket Pharmaceuticals | 374.33M |
| Fennec Pharmaceuticals | 373.11M |